Abstract -Rapid biochemical testing can expedite therapy i n key patient categories, particularly intensive care. Dry reagent chemistries have gone some way t o s a t i s f y i n g some of t h e s e requirements. However, chemical a n d b i o s e n s o r s o f f e r t h e p r o s p e c t s f o r more r o b u s t a n d operationally simpler near-patient analysers which, furthermore, a r e well s u i t e d t o t h e a s s a y of o p t i c a l l y o p a q u e b i o f l u i d s , as well as t h e development of cheaper instrumentation, The wide range of transduction principles on offer with sensing technology not only enhances prospects f o r success i n t h i s area, b u t permits more precise tailoring of sensor performance t o clinical requirements. Background considerations f o r extra-laboratory testing are reviewed here, together with discussion of key sensor properties and fabrication needs t h a t a r e of relevance t o measurement in these less controlled environments. An outline will then be given of t h e main t r a n s d u c e r t y p e s , including ion-selective and amperometric electrodes, thermistors, piezoelectric crystals and optical wave guides. Use of biomolecules w i l l centre on a description of enzyme and antibody incorporation into practical systems.
INTRODUCTION
The hospital biochemistry laboratories have grown from being an offshoot of pathology departments early t h i s century, t o being a self-contained, diagnostic resource i n its own r i g h t . The p r a c t i c e of modern-day medicine r e q u i r e s a r a p i d r e t u r n of high q u a l i t y biochemical data, no longer merely as a luxury contributing t o diagnostic precision, but as a virtually obligatory extension of t h e physical examination. There is added significance t o biochemical d a t a , s i n c e t h e y provide a q u a n t i t a t i v e i n d i c a t i o n of p a t i e n t s t a t u s , especially when therapy requires careful titration, as is t h e case in critical care medicine. Though administratively efficient and organisationally cohesive, location of a n e n t i r e analytical capability of a hospital on a single s i t e can no longer be accepted as ideal with respect t o efficient patient care (ref. 1). A key failing of centralisation is t h e relatively long t u r n around times f o r specimens requiring stat analysis, and which by t h e i r very nature are presented to t h e laboratory with a frequency and timing likely t o disturb t h e untrammelled throughput of t h e "batch" specimens (ref, 2).
A logical response to current needs is a greater flexibility in specimen analysis, with t h e setting up of satellite laboratories, frequently dedicated t o specific specialist units, e.g. n e o n a t a l a n d a d u l t i n t e n s i v e c a r e , r e n a l d i a l y s i s , c a r d i o t h o r a c i c s u r g e r y .
S u c h laboratories have been characterised by smaller t e s t repertoires serviced by small-scale analytical systems, s u f f i c i e n t l y u s e r -f r i e n d l y t o be o p e r a t e d , though n o t n e c e s s a r i l y serviced by staff with rudimentary analytical training.
evelo ment of automated blood gas analysers has been quickly followed by multi-ion (Ca", Nay, K' , Lit) and dry reagent analysers. Additional a t t r a c t i v e f e a t u r e s of many of t h e s e systems have been automatic trouble-shooting and computational f a c i l i t i e s (ref.
3). Many of t h e operating principles here a r e a departure from previous 'wet chemistry' systems, and minimise t h e need f o r reagent addition, sample preparation and repeat calibration. I t is t h e s e key attributes which can be more readily realised in chemical and biosensors, and which makes development of such devices f o r decentralised use particularly attractive. From t h e early days of t h e Clark oxygen electrode (ref. 4), experience of t h e special needs of clinical sensors is accumulating, and provides a pointer t o both t h e prospects and pit-falls of f u t u r e sensor use. Additional lessons a r e provided by t h e parallel and highly successful use of reflectance-based measurement, which has many of t h e functional a t t r i b u t e s of sensors. Thus, s u c c e s s f u l commercial systems s u c h as t h e Kodak Ektachem Analyser (Eastman Kodak, Rochester) and t h e Reflotron (Boehringer, Mannheim), illustrate t h e way in which reagent membrane l a y e r s , including t h o s e bearing metastable r e a g e n t s , can be laminated, manufactured on a large scale, stored and then rapidly reconstituted during use t o b o t h form a highly r e p r o d u c i b l e a s s a y matrix and a n o p t i c a l p a t h f o r r e f l e c t a n c e measurement. This does not, of course, preclude problems of operator e r r o r associated with specimen volume measurement, and t h e timing of a reaction. This possibility is supported by t h e finding of a generally unacceptable precision and accuracy d u r i n g evaluation of glucose reflectance meters away from controlled laboratory conditions (ref.
) .
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The sensor option
Chemical and biosensors have t h e potential t o exploit a diversity of transduction principles for the type of reagent layer components used in reflectance analysers. This should pave the way towards greater analytical flexibility and targeting t o precise clinical applications. A f u r t h e r attraction is t h a t it is now increasingly feasible t o adapt t h e fabrication and signal processing capabilities of the microelectronic and telecommunication industries t o sensors whereby miniaturisation, manufacture, multiplexing and signal modification are now much more easily realised.
A s constituted at present, analytical advantages of sensors reside i n t h e i r d i r e c t transduction of a given biochemical parameter, often with an electrical output that helps t o simplify t h e a t t e n d a n t i n s t r u m e n t a t i o n .
Also, i n c o n t r a s t t o s t a n d a r d spectrophotometric methods, the analysis of optically opaque samples, notably whole blood and tissue, comes within reach, clearly an advantage f o r near-patient monitoring. With many devices, t h e surface chemical o r bio-reagent is used principally as a recognition molecule; not only can this permit highly economical reagent reuse, but a non-destructive assay is possible. Such aspects have contributed, for example, t o the growing acceptance in clinical laboratories of ion-selective electrodes, the archetype non-destructive sensor. Implicit in this concept of molecular recognition is a reversible binding process which in turn enables response t o be reversible. In practice, t h i s may be difficult t o achieve, especially when t h e kinetics of dissociation a r e too slow (e.g. with immunosensors). However, for many devices, response can be made readily reversible, usually showing no hysteresis. Such systems confer the unique property of enabling continuous monitoring of an analyte, permitting better management of t h e critically ill patient, and can t a k e t h e form of transducer elements in artificial biofeedback systems (vide infra). For most clinical requirements, discrete analysis sensors, located i n varying proximity t o t h e patient, should prove satisfactory. Feeding into t h e overall equation in determining whether sensors will be used for home monitoring, at the bed-side, operating theatre, side ward o r satellite laboratory, w i l l be factors such as sensor robustness, ease of operation, availability, cost, prevailing medical ethics, and actual clinical value. A clear resolution of benefits is often difficult (ref, 6), a t least until any given system has been in place for some time, leading merely t o a retrospective assessment.
With growing efforts in industry, directed over the last decade t o providing sensors for medical diagnostics, t h e r e h a s been increased understanding of special functional requirements and fabrication needs of near-patient sensor systems. Some of t h e basic ground-rules are suggested in Table 1 . Manufacturer/purchaser requirements are indicated t o g e t h e r h e r e as t h e y r e a l l y form p a r t of a s i n g l e continuum of need t h a t is compartmentalised a t the risk of jeopardising both entities, and the ultimate successful deployment of sensors. A useful segregation, however, is t o consider ex vivo devices, used for intensive monitoring, reusable sensors for bench-top analysers, and "dip-sticks'' for hand-held meters separately. Table 1 shows some generalisations relating t o each of these types and which may help in the choice of measurement principles, though it is necessary t o recall t h a t the analytical route w i l l also be dictated by t h e measurand. I t is t h i s latter aspect t h a t dominates c u r r e n t thinking in sensor research, and which w i l l be highlighted in the succeeding section.
SENSOR SYSTEMS FOR SPECIFIC ANALYTES

Blood gases
The Clark electrode with its 02-permeable membrane compartmentalising and stabilising the electrolytic environment of its integral electrochemical cell, h a s proved a v i r t u a l l y immutable sensing principle f o r oxygen (ref. 7). Modernisation has taken t h e course of more modern materials with, f o r example, exploitation of semi-conductor fabrication techniques rather than transformation of underlying chemistry and miniature, disposable sensors, economical of electrode components have resulted (ref. 8). The principle of membrane compartmentalised bicarbonate solution has provided t h e basis of a selective (Severinghaus) CO2 electrode, ApC02 in blood here registering selectively as a ApH in the internal electrolyte (ref. 9). Miniaturisation of the glass pH membrane has been difficult, but with t h e advent of t h e ion-selective field effect t r a n s i s t o r (ISFET) (ref. l o ) , an inherent solid state construction combining with the H+ responsiveness of the insulator layers (SiOz, Si Nq), miniature, r o b u s t devices a r e possible. In a new design in t h e Mallinckrodt C E d analyser (ref. ll), an outer C02-permeable membrane also combining the function of H+ response is used t o respond t o the inner bicarbonate solution, external sample pH variation here being compensated for by a matching electrode containing wellbuffered internal electrolyte, For both 0 and CO , the ideal of non-invasive continuous monitoring has been achieved with heate$ skin efectrodes (ref, 12) . The principle exploiter here is t h e enhanced transcutaneous flux of gases resulting from skin heating (-43OC). Although increased tissue metabolic rate can lead t o underestimation of arterial p02, and an overestimate of pCO2, valuable information on pulmonary gas exchange is, nevertheless, obtained on a realt i m e basis. Usage is largely restricted t o critically ill neonates, where not only does the 
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Slcw reccplstitution on hydration acceptable Irmrediate r e m t i t u t i o n required *In vivo catheter devices are not considered here relatively t h i n s k i n allow g r e a t e r gas permeability f o r more accurate monitoring, b u t precipitous changes in blood gases warrant closer monitoring (ref. 13 ). This non-invasive technique carries t h e possibility of heat damage t o skin, and, therefore, regular change t o t h e monitoring s i t e is necessitated (2-4 hourly f o r neonates, 4-8 hourly in adults).
Optical sensing principles have been exploited f o r ex vivo monitoring of blood gases.
Here, an immobilised indicator dye, reacting reversibly with t h e measured parameter, is placed i n an optical p a t h configured with appropriate optical fibers. A fluorescent pH i n d i c a t o r dye h a s been used t o follow i n t e r n a l e l e c t r o l y t e pH change i n one t y p e of commercial optical pCOz sensor (CDI 300, Cardiovascular Devices Inc., Irvine CA) (ref. 14); in an alternative approach, an absorbance dye indicator has been employed (Cardiomet 4000, Shiley Inc., Irvine CA) (ref. 15). For pOz, concentration dependent oxygen quenching of dye fluorescence has proved t o be applicable (ref. 14), though dye photobleaching remains a problem.
Ions
Arterial pH has been a counterpart of respiratory gas measurement from t h e early days of monitoring. Most advances here have been those of sample presentation and flow-cell design, with a s s o c i a t e d modifications t o r e f e r e n c e / g l a s s e l e c t r o d e geometry ( r e f . 16), directed t o minimising maintenance requirements. The pH ISFET has been one important advance, f u r n i s h i n g a low impedance s i g n a l from a high impedance i n p u t (ref.
10); alternatives t o t h e glass pH membrane have included liquid membranes incorporatiug protein ionophore (ref. 17).
Ion measurement using potentiometric electrochemical cells has seen wide application in the central laboratory, now extended t o s m a l l bench-top analysers and through t o bedside systems. Selectivity and sensitivity limitations of current ion-selective membranes has meant a restriction in the measurement range of Na' , K ' , Ca2+, C1-and Li'. The validity of correlations with spectrophotometric methods which measure ion concentration rather than activity have led t o much debate and confusion i n t h e past. However, recent recommendation by one authority simply t o standardise electrodes (Na', K ' ) 
Metabolites
Enzymes have proved invaluable as selective substrate-degrading reagents for metabolite assay in Clinical Chemistry. Their incorporation as active layers in transducer elements has been both conceptually attractive and now practically realisable. The amperometric detection of hydrogen peroxide generated from oxidase enzymes, typically using a noble metal polarised at +0.6V (vs Ag/AgCl) has permitted assay of many metabolites of clinical interest, in particular, blood glucose and lactate. The Yellow Springs glucose electrode (YSI Inc., Ohio) has become a model f o r many other commercial instruments. Membrane technology was exploited here, whereby an external microporous membrane prevented contamination of t h e immobilised enzyme layer by sample colloids, with a subjacent permselective barrier reducing interference from diffusible electrochemically active species in blood. Need for sample dilution restricted use of t h i s analyser t o the laboratory environment. Extension of the linear operating range of such an enzyme electrode using external substrate limiting barrier membranes (refs. 19, 20) has made it possible t o analyse undiluted whole blood samples; t h i s principle has been used in t h e NOVA Stat-Profile glucose electrode (ref. 21) . A single use electrode, now marketed f o r home glucose monitoring, employs an electrochemically recyclable electron mediator t o substitute for 0 2 in the glucose oxidase reaction (Exact Tech, Medi Sense, Cambridge MA); this also permits assay of undiluted blood. Continuous, extracorporeal monitoring of glucose has been possible with t h e Biostator (Miles Lab., Elkhart) which houses a Yellow Springs-type membrane electrode in a low volume flow cell designed t o take diluted blood (ref. 22 ). More recently, such an electrode has been used in a system for monitoring haemofiltered blood (Betalike, Esacontrol SPA, Genova). Both monitors sample venous blood via a double lumen catheter designed t o achieve localised rather than systemic anticoagulation. Their additional clinical benefit resides in there being closed-loop systems for the computer controlled administration of insulin. Although needle enzyme electrodes are designed for invasive monitoring (ref. 23), they are usable in miniature flow cells (Fig. 1) and could help t o reduce the bulk size of such extracorporeal systems. Non-invasive glucose monitoring w a s reported by Ito e t a1 (ref. 24) who sampled effusion fluid from skin. After prior removal of t h e impermeable stratum corneum; negative pressure w a s employed t o promote fluid transfer. The electrode used w a s an oxidase coated ISFET responding t o local pH change resulting from t h e enzymic reaction. The drawback of such enzyme field effect transistors (ENFETs) is their strong dependence on sample buffer capacity and pH. Nevertheless, the integration of a biolayer with microelectronics is attractive, and pH sensing, furthermore, constitutes a near-universal detection for an enzymic reaction. Olthuis et a1 (ref. 25) have accordingly combined an activator system with the pH ISFET (Fig. 2) . This is designed t o maintain local pH constant, by coulometric generation of OH-(or H ' ) , t h e magnitude of t h e coulometric current for neutralisation providing a measure of enzymic H' generation and, therefore, substrate level, without reference t o buffer capacity. Another near-universal transducer element is t h e thermistor; its use in conjunction with immobilised enzyme reactor columns has enabled reagentless, though distinctive, substrate measurement by means of t h e detection of the heat of reaction (ref. 26 ). While only s m a l l temperature changes result, this approach holds promise for more robust, low-drift bedside monitors. The spectral selectivity of optical sensors will undoubtedly be exploited in f u t u r e bedside biochemical analysers. This area of development is at an earlier stage (ref. 
Antigenic species
An antigen at low concentration can be recognised by a sufficiently specific, high affinity antibody. Immunosensors have been designed t o u t i l i s e t h i s recognition p r o p e r t y of antibodies f o r t h e assay of drugs and protein molecules. In one general type of device, t h e direct immunosensor, t h e binding event itself is monitored. Thus, with an antibody immobilised t o t h e surface of a potentiometric sensor, interfacial charge effects lead t o electrode potential changes (ref. 30); over a piezoelectric crystal a change in vibration frequency of t h e c r y s t a l d u e t o weight change from t h e a n t i g e n mass bound may be monitored (ref. 31). While operationally highly convenient, t h e susceptibility of t h e s e probes t o simple background solution variables, and t h e inadequate s e n s i t i v i t y of t h e underlying transducer, still consigns them t o t h e experimental bench. This situation may change with improvements in signal accessing and t h e multiplexing of devices possessing a spectrum of response characteristics. More realistic has been t h e direct antibody coating of optical wave guides; here t h e evanescent wave, t h e electric vector of t h e light which extends i n t o t h e surface antibody phase, can be used t o interrogate any surface-bound antigen (analyte) provided it contains a s u i t a b l e chromophore (ref. 32) . In t h e second general type of transducer, t h e indirect immunosensor, t h e transducer element is used t o detect a change in t h e property of t h e labelled antigen following t h e immunoreaction, and if required, after separation of free from bound antigen. Assay here is along t h e lines of more conventional immunoassay and is more properly regarded as being i n t h e genre of non-isotopic immunoassay. Aizawa's g r o u p ( r e f . 33) measured a -f e t o p r o t e i n (AFP) by immobilisation of t h e appropriate antibody on an O2 electrode. Competition between catalase labelled and unlabelled AFP led t o variable catalase loading of t h e electrode, which was then determined from the electrode response t o H20Z; this typifies one popular approach with electrochemical detection. Antibodies immobilised on magnetic particles (ref. 34) have also been used, Here concentration of the antibody enzyme-labelled antigen complex in the vicinity of the electrode surface can be achieved by applying a magnetic field following immunoreaction in bulk solution. Enzyme retained within antigen-coated liposomes have allowed sensitive immunoassay; rupture of t h e coated liposome in t h e presence of complement and appropriate antibody serves a s a reporter system f o r the amount of free antigen in solution competing f o r t h e antibody; theophylline has been assayed in this way (ref. 35) . Hitherto, considerable ingenuity has been shown by basic researchers in developing immunosensor strategies; it is now likely that with equivalent advances in t h e formatting of such devices with a simplified sample presentation and automation, simple commercial near-patient immunosensors w i l l result.
CONCLUSIONS From t h e e a r l i e r phase of delineation and optimisation of basic chemical/biosensor chemistries, w e have now moved into an era of practical, multidisciplinary research. This has begun to critically address interfacing and biocompatibility issues (ref. 36) , in alliance with materials scientists, and t h e rationalisation of fabrication and formatting i n conjunction with instrument designers. A s a result, the transfer of biosensor devices from the academic t o the industrial sector has begun. Sensors are, thereby, s e t t o follow the development t r e n d s exemplified by dry reagent chemistries. Undoubtedly, t h e r e a r e deficiencies with many individual sensor systems with regard t o achieving exciting analytical targets in t h e clinical environment. However, even f o r systems with severe limitations, advances in electronic signal processing and associated development of the smart sensor (ref. 37) will bring about practical application.
